Senior counsel at Bayer highlights pharmaceutical TM challenges

15-03-2019

Senior counsel at Bayer highlights pharmaceutical TM challenges

photobyphm / Shutterstock.com

Doctors’ handwriting poses a significant challenge to the registration of pharmaceutical trademarks, according to a senior counsel at German pharmaceutical company Bayer.


Bayer, Chartered Institute of Trademark Attorneys, European Medicines Agency, Food and Drug Administration, pharmaceutical trademarks,

LSIPR